B
XPH icon

Baird’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Baird’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$7.51M Buy
121,536
+2,228
+2% +$132K 0.08% 254
2014
Q4 		$6.44M Sell
119,308
-400
-0.3% -$21.9K 0.07% 288
2014
Q3 		$6.34M Buy
119,708
+3,402
+3% +$173K 0.09% 210
2014
Q2 		$6.04M Buy
116,306
+1,222
+1% +$58.9K 0.08% 223
2014
Q1 		$5.39M Buy
115,084
+6,494
+6% +$307K 0.08% 254
2013
Q4 		$4.78M Buy
108,590
+1,976
+2% +$82.3K 0.08% 267
2013
Q3 		$4.1M Buy
106,614
+4,622
+5% +$175K 0.08% 293
2013
Q2 		$3.6M Buy
+101,992
New +$3.44M 0.07% 295

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return